📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Occlutech

1.1 - Company Overview

Occlutech Logo

Occlutech

Headquarter: Sweden
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of cardiac occlusion devices and other vascular implants, offering the PFO Occluder for patent foramen ovale closure to reduce recurrent stroke, the UNI Occluder for multi-fenestrated atrial septal defects as a surgical alternative, and accessory tools (Pistol Pusher, Flex-II Pusher) for device implantation.

Products and services

  • Accessory Medical Devices: Includes the Pistol Pusher and Flex-II Pusher, implantation-specific tools used in the implantation of cardiac occlusion devices
  • PFO Occluder: Closes patent foramen ovale to reduce recurrent stroke, featuring conformable Nitinol braiding and a biocompatible surface
  • UNI Occluder: An occlusion device intended for the closure of multi-fenestrated atrial septal defects, offering an alternative to surgical approaches

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Occlutech

RR Mechatronics Logo

RR Mechatronics

HQ: The Netherlands Website
  • Description: Provider of analytics laboratory instruments for the medical diagnosis industry.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full RR Mechatronics company profile →
Endocardial Solutions Logo

Endocardial Solutions

HQ: United States Website
  • Description: Provider of a minimally invasive diagnostic system that diagnoses tachycardia, a potentially fatal abnormal heart rhythm, within a few heartbeats, using its proprietary EnSite catheter and clinical workstation.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Endocardial Solutions company profile →
AccessClosure Logo

AccessClosure

HQ: United States Website
  • Description: Provider of access site management products for vascular closure during interventional and diagnostic procedures, including the Mynx delivery system, a vascular closure device that seals the arteriotomy using a water-soluble, extravascular sealant.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full AccessClosure company profile →
CeloNova BioSciences Logo

CeloNova BioSciences

HQ: United States Website
  • Description: Provider of interventional cardiology and endovascular products, including Polyzene-F nano-thin biomimetic coatings for implants to reduce thrombogenicity, inflammation and promote rapid healing; Xero-Gel drug-coated PTCA balloons for small vessel stenosis, restenosis and bifurcations; and COBRA PzF NanoCoated non-drug eluting coronary stents for patients with a short 1-month dual antiplatelet therapy requirement. Offers partnership and co-development opportunities.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full CeloNova BioSciences company profile →
GB Sciences Logo

GB Sciences

HQ: United States Website
  • Description: Provider of research and biotechnical development focused on plant-based therapeutics, including the PhAROS AI drug discovery platform to identify and predict active ingredients; therapies for Parkinson’s disease (animal proof-of-concept, US patent); COVID-related cytokine release syndrome therapies (positive proof-of-concept); and oral nanoparticle pain therapeutics (US patent, ongoing animal studies).
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full GB Sciences company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Occlutech

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Occlutech

2.2 - Growth funds investing in similar companies to Occlutech

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Occlutech

4.2 - Public trading comparable groups for Occlutech

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Occlutech

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Occlutech

What does Occlutech do?

Occlutech is a provider of cardiac occlusion devices and other vascular implants, offering the PFO Occluder for patent foramen ovale closure to reduce recurrent stroke, the UNI Occluder for multi-fenestrated atrial septal defects as a surgical alternative, and accessory tools (Pistol Pusher, Flex-II Pusher) for device implantation.

Who are Occlutech's competitors?

Occlutech's competitors and similar companies include RR Mechatronics, Endocardial Solutions, AccessClosure, CeloNova BioSciences, and GB Sciences.

Where is Occlutech headquartered?

Occlutech is headquartered in Sweden.

How many employees does Occlutech have?

Occlutech has 1,000 employees 🔒.

When was Occlutech founded?

Occlutech was founded in 2010 🔒.

What sector and industry vertical is Occlutech in?

Occlutech is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Occlutech

Who are the top strategic acquirers in Occlutech's sector and industry

Top strategic M&A buyers and acquirers in Occlutech's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Occlutech?

Top strategic M&A buyers groups and sectors for Occlutech include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Occlutech's sector and industry vertical

Which are the top PE firms investing in Occlutech's sector and industry vertical?

Top PE firms investing in Occlutech's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Occlutech's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Occlutech's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Occlutech's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Occlutech include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Occlutech's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Occlutech?

The key public trading comparables and valuation benchmarks for Occlutech include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Occlutech for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Occlutech with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Occlutech's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Occlutech with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Occlutech's' sector and industry vertical?

Access recent funding rounds and capital raises in Occlutech's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Occlutech